Pfizer, Arvinas ink licensing deal with Rigel for breast cancer therapy
Pfizer Inc. · PHARMACEUTICAL PREPARATIONS · Now $25.63
-2.1% in 3d after detection
Post-detection moves
1h
—
1d
+0.3%
3d
-2.1%
7d
+0.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS